These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20200429)

  • 1. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
    Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Grioni S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):729-37. PubMed ID: 20200429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
    Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
    J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
    Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
    Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary melatonin levels and breast cancer risk.
    Schernhammer ES; Hankinson SE
    J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
    Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
    [No Abstract]   [Full Text] [Related]  

  • 6. Melatonin and breast cancer: a prospective study.
    Travis RC; Allen DS; Fentiman IS; Key TJ
    J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort.
    Schernhammer ES; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):74-9. PubMed ID: 19124483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Melatonin in Relation to Breast Cancer Risk: Nested Case-Control Analysis in the DOM Study and Meta-analysis of Prospective Studies.
    Wong ATY; Fensom GK; Key TJ; Onland-Moret NC; Tong TYN; Travis RC
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):97-103. PubMed ID: 33144281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.
    Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC
    Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.
    Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR
    Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
    Bartsch C; Bartsch H; Karenovics A; Franz H; Peiker G; Mecke D
    J Pineal Res; 1997 Sep; 23(2):53-8. PubMed ID: 9392442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.
    Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels.
    Schernhammer ES; Kroenke CH; Dowsett M; Folkerd E; Hankinson SE
    J Pineal Res; 2006 Mar; 40(2):116-24. PubMed ID: 16441548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer.
    Barba M; Cavalleri A; Schünemann HJ; Krogh V; Evangelista A; Secreto G; Micheli A; Zhou Q; Fuhrman B; Teter B; Berrino F; Muti P
    Int J Biol Markers; 2006; 21(4):242-5. PubMed ID: 17177163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women.
    Travis RC; Allen NE; Peeters PH; van Noord PA; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):806-8. PubMed ID: 12917214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-sulphatoxymelatonin production in breast cancer patients.
    Skene DJ; Bojkowski CJ; Currie JE; Wright J; Boulter PS; Arendt J
    J Pineal Res; 1990; 8(3):269-76. PubMed ID: 2380908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.